Yuichi Iwaki
Founder at MEDICINOVA, INC.
Net worth: 1 M $ as of 29/04/2024
Yuichi Iwaki active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDICINOVA, INC. | Director/Board Member | 28/02/2007 | - |
| Chief Executive Officer | 31/07/2005 | - | |
| Founder | 25/09/2000 | - | |
| President | 28/02/2006 | - | |
| Chairman | 25/09/2000 | 28/02/2007 | |
| Director of Finance/CFO | 21/04/2020 | 18/06/2020 | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Chief Executive Officer | 17/12/2009 | - |
| Director/Board Member | 31/10/1994 | 17/12/2009 | |
| University of South Carolina School of Medicine | Corporate Officer/Principal | 31/12/1991 | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - | - |
Career history of Yuichi Iwaki
Former positions of Yuichi Iwaki
| Companies | Position | Start | End |
|---|---|---|---|
| University of Pittsburgh School of Medicine | Corporate Officer/Principal | 31/12/1988 | 31/12/1990 |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Director/Board Member | - | - |
| AMCOL INTERNATIONAL CORPORATION | Chairman | - | - |
| President | - | - |
Training of Yuichi Iwaki
| Sapporo Medical University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 8 |
| Japan | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
AMCOL International Corp.
 AMCOL International Corp. Construction MaterialsNon-Energy Minerals AMCOL International Corp. produces value-added, specialty minerals, and related product. The company was founded on December 30, 1959 and is headquartered in Hoffman Estates, IL. | Non-Energy Minerals |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Health Technology |
- Stock Market
- Insiders
- Yuichi Iwaki
- Experience
